BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 25017022)

  • 1. BTG1 expression in thyroid carcinoma: diagnostic indicator and prognostic marker.
    Lu YF; Sun GG; Liu Q; Yang CR; Cheng YJ
    Int J Oncol; 2014 Oct; 45(4):1574-82. PubMed ID: 25017022
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The expression of BTG1 is downregulated in nasopharyngeal carcinoma and possibly associated with tumour metastasis.
    Sun GG; Wang YD; Cheng YJ; Hu WN
    Mol Biol Rep; 2014 Sep; 41(9):5979-88. PubMed ID: 24985971
    [TBL] [Abstract][Full Text] [Related]  

  • 3. B cell translocation gene 1 reduces the biological outcome of kidney cancer through induction of cell proliferation, cell cycle arrest, cell apoptosis and cell metastasis.
    Sun G; Liu Q; Cheng Y; Hu W
    Int J Mol Med; 2015 Mar; 35(3):777-83. PubMed ID: 25571854
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BTG1 underexpression is an independent prognostic marker in esophageal squamous cell carcinoma.
    Sun GG; Wang YD; Cheng YJ; Hu WN
    Tumour Biol; 2014 Oct; 35(10):9707-16. PubMed ID: 24969561
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of EMP1 with gastric carcinoma invasion, survival and prognosis.
    Sun G; Zhao G; Lu Y; Wang Y; Yang C
    Int J Oncol; 2014 Sep; 45(3):1091-8. PubMed ID: 24920167
    [TBL] [Abstract][Full Text] [Related]  

  • 6. BTG1 expression correlates with pathogenesis, aggressive behaviors and prognosis of gastric cancer: a potential target for gene therapy.
    Zheng HC; Li J; Shen DF; Yang XF; Zhao S; Wu YZ; Takano Y; Sun HZ; Su RJ; Luo JS; Gou WF
    Oncotarget; 2015 Aug; 6(23):19685-705. PubMed ID: 26050197
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of BTG1 in hepatocellular carcinoma and its correlation with cell cycles, cell apoptosis, and cell metastasis.
    Sun GG; Lu YF; Cheng YJ; Yang CR; Liu Q; Jing SW; Han XC
    Tumour Biol; 2014 Dec; 35(12):11771-9. PubMed ID: 25173640
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The expression of BTG1 is downregulated in NSCLC and possibly associated with tumor metastasis.
    Sun GG; Lu YF; Cheng YJ; Hu WN
    Tumour Biol; 2014 Apr; 35(4):2949-57. PubMed ID: 24264312
    [TBL] [Abstract][Full Text] [Related]  

  • 9. BTG1 expression correlates with the pathogenesis and progression of breast carcinomas.
    Sheng SH; Zhao CM; Sun GG
    Tumour Biol; 2014 Apr; 35(4):3317-26. PubMed ID: 24272202
    [TBL] [Abstract][Full Text] [Related]  

  • 10. B‑cell translocation gene 1 serves as a novel prognostic indicator of hepatocellular carcinoma.
    Kanda M; Sugimoto H; Nomoto S; Oya H; Hibino S; Shimizu D; Takami H; Hashimoto R; Okamura Y; Yamada S; Fujii T; Nakayama G; Koike M; Fujiwara M; Kodera Y
    Int J Oncol; 2015 Feb; 46(2):641-8. PubMed ID: 25405901
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CCNG2 suppressor biological effects on thyroid cancer cell through promotion of CDK2 degradation.
    Li WJ; Liu GL; Yu F; Xiang XX; Lu YF; Xiao HZ; Shi YP
    Asian Pac J Cancer Prev; 2013; 14(10):6165-71. PubMed ID: 24289643
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BTG1 inhibits breast cancer cell growth through induction of cell cycle arrest and apoptosis.
    Zhu R; Zou ST; Wan JM; Li W; Li XL; Zhu W
    Oncol Rep; 2013 Nov; 30(5):2137-44. PubMed ID: 23982470
    [TBL] [Abstract][Full Text] [Related]  

  • 13. B‑cell translocation 1 gene inhibits cellular metastasis‑associated behavior in breast cancer.
    Li W; Zou ST; Zhu R; Wan JM; Xu Y; Wu HR
    Mol Med Rep; 2014 Jun; 9(6):2374-80. PubMed ID: 24714932
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The treatment effects and the underlying mechanism of B cell translocation gene 1 on the oncogenesis of brain glioma.
    Qian Y; Lu X; Li Q; Zhao S; Fang D
    J Cell Biochem; 2019 Aug; 120(8):13310-13320. PubMed ID: 30916818
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Relationship between raf kinase inhibitor protein and metastasis of ovarian carcinoma].
    Wang Y; Yang J; Gao Y; Zhao XL; Li HZ; Yao Z
    Zhonghua Fu Chan Ke Za Zhi; 2009 Jul; 44(7):522-8. PubMed ID: 19957553
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of livin in gastric cancer and induction of apoptosis in SGC-7901 cells by shRNA-mediated silencing of livin gene.
    Wang TS; Ding QQ; Guo RH; Shen H; Sun J; Lu KH; You SH; Ge HM; Shu YQ; Liu P
    Biomed Pharmacother; 2010 May; 64(5):333-8. PubMed ID: 19914791
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Livin may serve as a marker for prognosis of bladder cancer relapse and a target of bladder cancer treatment.
    Liu HB; Kong CZ; Zeng Y; Liu XK; Bi JB; Jiang YJ; Han S
    Urol Oncol; 2009; 27(3):277-83. PubMed ID: 18555709
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic significance of low expression of B-cell translocation gene 1 (
    Li G; Yue Y; Li W; Chen Y; Fan H; Yuan J; Chen Z; Liu J
    J Biosci; 2020; 45():. PubMed ID: 32457282
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High expression of PRL-3 can promote growth of gastric cancer and exhibits a poor prognostic impact on patients.
    Wang Z; Cai SR; He YL; Zhan WH; Chen CQ; Cui J; Wu WH; Wu H; Song W; Zhang CH; Peng JJ; Huang XH
    Ann Surg Oncol; 2009 Jan; 16(1):208-19. PubMed ID: 19009246
    [TBL] [Abstract][Full Text] [Related]  

  • 20. STAT3 mRNA and protein expression in colorectal cancer: effects on STAT3-inducible targets linked to cell survival and proliferation.
    Lassmann S; Schuster I; Walch A; Göbel H; Jütting U; Makowiec F; Hopt U; Werner M
    J Clin Pathol; 2007 Feb; 60(2):173-9. PubMed ID: 17264243
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.